HOME >> MEDICINE >> NEWS
Men more at risk of recurrent blood clots than women

Men have a 50% higher relative risk of suffering from recurrent blood clots after a first episode than women, according to an article in this week's issue of The Lancet. The baseline frequency of recurrent blood clots is 25% after five years.

Dr Simon McRae from the Department of Haematology (Queen Elizabeth Hospital, Woodville, South Australia, Australia) and his colleagues from the Department of Medicine, McMaster University (Hamilton, Ontario, Canada) did a meta-analysis of studies involving both men and women who were being treated for either deep vein thrombosis or pulmonary embolism (in which a clot detaches from a deep vein and lodges in the lung). They looked at rates of recurrence of blood clots in patients after they had stopped taking preventative anticoagulant (blood-thinning) medication.

A total of 5416 patients were enrolled in 15 eligible studies, 50% were men and 50% women. There were 816 recurrent blood clots, of which 523 (64%) were in men and 293 (36%) were in women.

The cause of heightened risk in men is unclear, but the authors state it could be attributable to differences in age, body mass index, or inherited susceptibility to blood clots. Dr Simon McRae writes: "further prospective studies are needed before a firm recommendation can be made to incorporate patient sex into decision making on duration of anticoagulant treatment in individual patients."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
27-Jul-2006


Page: 1

Related medicine news :

1. Vorinostat shows anti-cancer activity in recurrent gliomas
2. New class of targeted cancer drugs shows promise in slowing progression of recurrent prostate cancer
3. Popular statin reduces recurrent stroke risk
4. Measurement of urinary protein can help detect recurrent bladder cancer
5. Point-of-care test proves more effective for recurrent bladder cancer than conventional lab test
6. Antibiotics do not prevent recurrent myocardial infarcts in subjects with periodontitis
7. Study suggests mechanism for recurrent sudden infant death syndrome
8. Biomarkers may provide important information for patients at risk for recurrent ischemic stroke
9. Treatment regimen offers greater survival advantage for recurrent head and neck cancers
10. Biomarkers used to predict recurrent disease in hepatitis C transplant patients
11. Antidepressants may lower risk of recurrent heart attack in depressed heart attack patients

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Men more risk recurrent blood clots than women

(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, ... vitro fertilization (IVF) -- the incubation of embryos in a ... inside the vagina, new research suggests. Scientists from the ... INVOcell, might sharply cut costs for pricey IVF procedures among ... to those who don,t live near big-city assisted reproduction centers, ...
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter ... was diagnosed with Ebola while working for NBC News ... leave the special isolation unit at Nebraska Medical Center in Omaha, ... hospital said Tuesday. A blood test confirmed by the U.S. ... can head home to Providence, R.I., NBC News reported ...
(Date:10/20/2014)... PA (PRWEB) October 20, 2014 Allegheny ... minimally-invasive procedure that enables physicians to repair a damaged ... The MitraClip system, developed by Abbott ... (MR), a progressive and life-threatening condition in which the ... blood to flow backward from the heart’s left ventricle ...
(Date:10/20/2014)... Women’s health specialist, Dr. Amber Murphy, MD, ... Columbus, Inc., A Division of MaternOhio Clinical Associates, Inc., ... 100,000 patients annually. Dr. Murphy will provide a full ... a women’s life. She is accepting new patients at ... Dublin. , Dr. Murphy offers a wide variety of ...
(Date:10/20/2014)... Zereana Jess-Huff, a 34-year-old mother, corporate executive and ... platform to think outside the bra. She doesn’t try to ... raise awareness about women’s other lady parts. , "We have ... the color pink and everybody knows what you’re talking about,” ... it has not been won when it comes to gynecologic ...
Breaking Medicine News(10 mins):Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 2Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 3Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3
(Date:10/22/2014)... 2014   Surefire Medical , Inc., the developer ... maximize targeted delivery of embolization agents in minimally invasive ... John R. Daniels , MD of the University ... oncologist Steven C. Katz , MD of the ... Advisory Board (SAB).    "The role of ...
(Date:10/22/2014)... Oct. 22, 2014 Provectus Biopharmaceuticals, Inc. (NYSEMKT: ... its novel investigational drug for cancer, is designed for ... side effects. Its oncology focus is on melanoma, breast ... phase 2 trials of PV-10 as a therapy for ... for atopic dermatitis and psoriasis. This ...
(Date:10/20/2014)... Calif. , Oct. 20, 2014  PneumRx, Inc. ... interventional pulmonology, today announced completion of enrollment in their ... RENEW Clinical Study is the FDA-approved IDE pivotal trial ... severe emphysema. It was anticipated that the ... February 2013, would take until the end of 2014 ...
Breaking Medicine Technology:Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3
Cached News: